%20CORP.%2C%20LTD./other/SHANGHAI_OBIO_TECHNOLOGY_GROUP_CORP.__QsWgeBs.png)
SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD. — Investor Relations & Filings
SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD. is a specialized Contract Development and Manufacturing Organization (CDMO) focused on the gene and cell therapy (GCT) sector. The company provides end-to-end solutions encompassing vector construction, process development, analytical method development, and large-scale GMP manufacturing. Its service portfolio includes the production of viral vectors such as adeno-associated virus (AAV), lentivirus, adenovirus, and oncolytic viruses, as well as plasmid DNA and cell therapy products. Obio Technology supports clients from early-stage research through clinical trials to commercialization. The company operates advanced facilities designed to meet international regulatory standards, facilitating the development of innovative genetic medicines and advanced therapies for global biopharmaceutical partners.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 2024年第一次临时股东大会决议公告 | 2024-02-28 | Chinese | |
| 2023年度业绩快报公告 | 2024-02-23 | Chinese | |
| 上海市金茂律师事务所关于和元生物技术(上海)股份有限公司第一期员工持股计划的法律意见书 | 2024-02-23 | Chinese | |
| 2024年第一次临时股东大会会议资料 | 2024-02-19 | Chinese | |
| 第一期员工持股计划管理办法 | 2024-02-07 | Chinese | |
| 监事会关于公司第一期员工持股计划相关事项的核查意见 | 2024-02-07 | Chinese |
Browse filings by year
5 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 40067490 | 2024年第一次临时股东大会决议公告 | 2024-02-28 | Chinese | ||
| 40067471 | 2023年度业绩快报公告 | 2024-02-23 | Chinese | ||
| 40067457 | 上海市金茂律师事务所关于和元生物技术(上海)股份有限公司第一期员工持股计划的法律意见书 | 2024-02-23 | Chinese | ||
| 40067434 | 2024年第一次临时股东大会会议资料 | 2024-02-19 | Chinese | ||
| 40067414 | 第一期员工持股计划管理办法 | 2024-02-07 | Chinese | ||
| 40067398 | 监事会关于公司第一期员工持股计划相关事项的核查意见 | 2024-02-07 | Chinese | ||
| 40067377 | 第一期员工持股计划(草案)摘要 | 2024-02-07 | Chinese | ||
| 40067347 | 《和元生物技术(上海)股份有限公司信息披露管理制度》 | 2024-02-07 | Chinese | ||
| 40067333 | 《和元生物技术(上海)股份有限公司投资者关系管理制度》 | 2024-02-07 | Chinese | ||
| 40067317 | 《和元生物技术(上海)股份有限公司章程》(2024年2月) | 2024-02-07 | Chinese | ||
| 40067282 | 第三届董事会第十二次会议决议公告 | 2024-02-07 | Chinese | ||
| 40067269 | 2024年第一次职工代表大会决议公告 | 2024-02-07 | Chinese | ||
| 40067253 | 《和元生物技术(上海)股份有限公司募集资金管理制度》 | 2024-02-07 | Chinese | ||
| 40067239 | 关于召开2024年第一次临时股东大会的通知 | 2024-02-07 | Chinese | ||
| 40067222 | 关于修订《公司章程》及制定、修订公司部分治理制度的公告 | 2024-02-07 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58266/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58266 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58266 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58266 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58266}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD. (id: 58266)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.